Gene expression of Lymphoblastoid Cell Lines (LCLs) from Depressed Patients after in-vitro treatment with fluoxetine. Homo sapiens

We used whole gene gene expression profiling to identify potential gene expression biomarkers associated for the treatment individualization of depressive disorders. Overall design: Gene expression was measured after 21 days of in-vitro treatment with therapeutical concentrations of fluoxetine in n=10 LCLs derived from depressed patients with documented clinical treatment outcome.